Viewing StudyNCT05927857



Ignite Creation Date: 2024-05-06 @ 7:12 PM
Last Modification Date: 2024-10-26 @ 3:02 PM
Study NCT ID: NCT05927857
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-07-03
First Post: 2023-06-14

Brief Title: Ramucirumab Cyramza Nal-IRI ONIVYDE and TrifluridineTipiracil Lonsurf in Second Line Metastatic Gastric Cancer
Sponsor: National Health Research Institutes Taiwan
Organization: National Health Research Institutes Taiwan

Conditions & Keywords Data

Conditions:
Name
Metastatic Gastric Adenocarcinoma
Second Line
Chemotherapy
Keywords:
Name View
nal-IRI ONIVYDE View
TAS-102 LONSURF View
Ramucirumab Cyramza View